InsiderTrades

Form 4 for ASTH Astrana Health, Inc.

Accepted 2025-12-10 00:00:00 ET · period of report 2025-12-08 · accession 0001104659-25-119985 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-10 2025-12-08 ASTH Lam Thomas S. Dir M - OptEx $17.78 +29.5K 459.1K +7% +$524.5K
D 2025-12-10 2025-12-08 ASTH Lam Thomas S. Dir F - Tax $22.00 -25.9K 433.3K -6% -$569.1K
D 2025-12-10 2025-12-08 ASTH Lam Thomas S. Dir M - OptEx $0.00 -29.5K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-08 M A 29,502 $17.78 459,122 D — —
2 Common Common Stock 2025-12-08 F D 25,866 $22.00 433,256 D — — (F3) Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 77,500 shares, which will vest in three equal annual installments beginning on March 5, 2026; and (ii) 26,667 shares, which will vest upon achievement of certain pre-established performance goals.
3 Derivative Stock Option (right to buy) 2025-12-08 M D 29,502 $0.00 0 D $17.78 · — to 2025-12-10 29,502 Common Stock (F2) These stock options were fully vested and exercisable.